Format

Send to

Choose Destination
Curr Opin Rheumatol. 2016 Sep;28(5):544-9. doi: 10.1097/BOR.0000000000000316.

Uveitis in children.

Author information

1
aEmory University School of Medicine, Atlanta, Georgia bDuke University, Durham, North Carolina, USA.

Abstract

PURPOSE OF REVIEW:

The review provides updates on novel risk markers for the development of pediatric inflammatory uveitis and a severe disease course, on treatment of refractory disease, and on the measurement of visual outcomes.

RECENT FINDINGS:

There are several new genetic markers, biomarkers, and clinical factors that may influence a child's uveitis disease course. It is important to identify children at risk for poor visual outcomes and who are refractory to traditional therapy. Racial disparities have recently been reported. We describe agents of potential benefit. In addition, we discuss the importance of patient reported outcomes in this population.

SUMMARY:

Uveitis can lead to vision-threatening complications. Timely and aggressive treatment of children identified to be at risk for a severe uveitis course may lead to improved outcomes.

PMID:
27328333
PMCID:
PMC4965315
DOI:
10.1097/BOR.0000000000000316
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wolters Kluwer Icon for PubMed Central
Loading ...
Support Center